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Abstract 
 
The goal of this work is to review the principles, design, and function of the ISS multilateral medical 
authority and the medical support system of the ISS Program. Multilateral boards and panels provide 
operational framework, direct, and supervise the ISS joint medical operational activities. The Integrated 
Medical Group (IMG) provides front-line medical support of the crews.  Results of ongoing activities are 
reviewed weekly by physician managers. A broader status review is conducted monthly to project the state of 
crew health and medical support for the following month. All boards, panels, and groups function effectively 
and without interruptions. Consensus prevails as the primary nature of decisions made by all ISS medical 
groups, including the ISS medical certification board. The sustained efforts of all partners have resulted in 
favorable medical outcomes of the initial fourteen long-duration expeditions. The medical support system 
appears to be mature and ready for further expansion of the roles of all Partners, and for the anticipated increase 
in the size of ISS crews. 
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1. Introduction 
 
The current stage of human spaceflight is characterized by unprecedented technological 
advancements and broad international cooperation in the assembly and operation of the International 
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Space Station (ISS). Medical support is among the areas where synergistic inputs from all Partners 
(Russian Federal Space Agency (FSA), the U.S. National Aeronautics and Space Administration 
(NASA), the European Space Agency (ESA), the Canadian Space Agency (CSA), and the Japan 
Aerospace Exploration Agency (JAXA)) have resulted in a robust and highly effective multilateral 
system.  
Up to the mid-1990s, the medical support systems for human space flight in Russia and the 
U.S. differed substantially. However, the founding documents of the ISS Program called for 
integration of medical support through integrated crews, a common system of medical support, and 
coordination of crew health matters on the principle of consensus.[1,2] Efforts and resources of all 
Partners were to be coordinated for the development and operation of a joint system that would best 
maintain health and performance of international crews in all phases of ISS missions.  In order to 
overcome the differences and integrate the national systems of medical support, a number of 
objectives were identified, first during the phase of preparation and implementation of the U.S.–
Russian Shuttle-Mir and NASA-Mir projects [3,4,5], and later within the framework of multilateral 
cooperation for ISS. These objectives included reduction and mitigation of risks associated with space 
flight factors that were distinct in their nature, as well as establishment of environmental conditions in 
habitable compartments of the spacecraft that were conducive to healthy and productive life and 
work. It was particularly important to provide readily available, effective means and methods of in-
flight countermeasures to mitigate the well-known adverse effects of long-duration space flight on 
crew health [6-8]. Water, food products, air, and the station interior had to be verifiably clean, 
healthy, and free of toxic impurities and microbiological contamination. Risks had to be predicted and 
analyzed for nominal flight conditions (launch, dynamic on-orbit operations, EVA, implementation of 
complex flight programs, and crew return), as well as for the occurrence of various off-nominal 
situations such as malfunctions of station engineering systems including life support, and failures of 
medical and exercise equipment. An acceptable crew work/rest schedule had to be worked out, 
balancing work, exercise, personal time, and sleep, since crew fatigue is known to be a leading cause 
of performance decrements and operator errors [9-10]. Finally, the station was to be equipped to 
identify and treat predictable medical situations on orbit, and to provide means for safe medical 
evacuation in case of life-threatening emergencies.  
Thus, notwithstanding the experience accumulated in all pre-ISS programs and broadly 
available through many review publications, creation of a common, consensus-based system for 
medical support of joint crews posed a substantial challenge.  Utmost regard and respectful 
consideration was given by each partner for the knowledge and experience of the others, as well as to 
their established regulations and procedures for crew medical support. Many large and small 
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obstacles were encountered and overcome to achieve integration and standardization. The cumulative 
effect of the many previous years of international cooperation in space biology and medicine, along 
with the leadership of the space medicine managers and experts of all Partners, created favorable 
conditions for continued cooperation and integration. A number of developments were highly 
contributory to the development of an effective ISS crew medical support system: interaction and 
joint operations by NASA and FSA medical communities in the Phase 1 program[4,5]; the 
establishment and operation of the ISS medical boards, panels and working groups; the development 
of the common ISS medical requirements; adoption of common ISS medical selection standards and 
evaluation requirements; the joint certification of the first four ISS expedition crews; exchanges of 
personnel including flight surgeons, and the adoption of the concepts of the Integrated Medical 
System (IMedS) onboard and the Integrated Medical Group (IMG) on the ground.  The joint efforts of 
all the Partner medical organizations resulted in an effective international system of operational 
medical support.  
 
2. Main documents regulating international cooperation on the ISS 
 
The cooperation in construction and operation of the ISS was initiated and authorized by the 
Agreement Among the Government of Canada, Governments of the Member States of the European 
Space Agency, the Government of Japan, the Government of the Russian Federation, and the 
Government of the United States of America Concerning Cooperation on the Civil International 
Space Station, signed in January of 1998 (the Intergovernmental Agreement, or IGA)[1]. The IGA 
recalls all international space treaties that led to the ultimate development of an international 
partnership to build and operate the ISS. It recognizes the Russian Federation’s “unique experience 
and accomplishments in the area of human space flight and long-duration missions, including the 
successful long-term operation of the Russian Mir Space Station.”  The IGA further stipulates that the 
United States has the leading role for overall ISS management and coordination, and that detailed 
provisions for implementation of the agreement would be developed in Memoranda of Understanding 
(MOU).  These MOUs were subsequently developed and signed as bilateral agreements between 
NASA and each ISS partner, i.e. the Russian Space Agency, the European Space Agency, the 
Canadian Space Agency, and the Government of Japan. 
The basic principles governing the ISS crew health matters are defined in Article 11.4 of each 
ISS MOUs [2] (Appendix). This Article authorizes three multilateral forums of medical authority, 
namely the Multilateral Medical Policy Board (MMPB), the Multilateral Space Medicine Board 
(MSMB), and the Multilateral Medical Operations Panel (MMOP), and provides a framework for 
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consensus-building based on discussion and negotiation, which proved to be viable over time. 
Conflict resolution mechanisms built into the IGA and MOU’s to assure decision-making capacity of 
the multilateral groups. However, decisions of medical nature, such as those on space flight medical 
eligibility of particular individuals, were to remain the prerogative of medical specialists. 
 
3. ISS Multilateral Medical Authority Structure and Medical Policy Framework 
 
As noted above, the Article 11.4 of the ISS MOUs establishes a multilateral medical authority 
structure and calls for a joint system of medical support. The entire ISS medical organization is 
designed on the premise of full cooperation and active participation of all partner members. The 
MMPB, the MSMB, and the MMOP are the original groups expected to further develop and 
implement policies, standards, requirements, and operational mechanisms in the framework of the ISS 
partnership. Groups and forums were thus established to create a system of operational medical 
services for the ISS. Charters of the three multilateral groups became the initial vehicle to implement 
the guidance of the MOUs. A considerable effort was applied by all Partners to define roles, 
responsibilities, and primary functional features of these groups.  Considerations were addressed 
regarding the sensitive nature of the medical authority and the need for decision-making capacity 
based primarily on medical and safety considerations, without undue bias or influence. The ISS 
medical authority structure is depicted in Figure 1. 
 
3.1 The Multilateral Medical Policy Board (MMPB) and ISS Medical Policy 
The MMPB is the highest level of medical authority responsible for medical policy formulation 
and oversight of all crew health-related matters.  While members of the MMPB are answerable to 
their respective agencies, the Board as a whole exercises its authority independently of the ISS 
management bodies and operates on the basis of coordinated decisions (consensus). The NASA and 
FSA members of the MMPB co-chair the Board until the ISS assembly is completed.  MMPB issues 
medical policy decisions through special Policy Directives, statements in meeting Minutes, letters, 
and review of high-level ISS documents, such as charters, sets of standards, and requirements. A most 
prominent feature of MMPB has been its adherence to the fundamental principles discussed below.  
3.1.1 Integrated approach to medical policy:  With a goal to ensure the best possible health 
outcomes for the ISS crew, the MMPB explicitly pronounced an integrated approach to medical 
policy, requiring and upholding an integrated health support system operating on the best available 
evidence, with the best available resources and highest ethical standards, as a component “essential to 
the success of the ISS”.  
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3.1.2 Evidence-based, scientific approach to the operation of the ISS medical support 
system:  The MMPB has made a commitment to supporting International Partners’ cooperative work 
“to reach a common understanding based on the best available scientific evidence… with the goal of 
making informed decisions.” Furthermore, the favorable health outcomes of human space flight in 
both the U.S. and the Russian space programs was seen as evidence of the success of both systems, 
which formed a basis for continued progress in the development and operation of the new medical 
support system. Scientific evidence from both space and terrestrial medical practice and research is 
broadly used throughout the ISS medical community, from medical certification of crewmembers to 
in-flight countermeasures and environmental health assurance, to postflight rehabilitation of long-
duration crews.  
3.1.3 Common Space Medicine Standards.  Early in the ISS operations, the ISS medical 
policy supported adherence to the existing space medicine standards already agreed upon.  MMOP 
and MSMB undertook the development of common space medicine standards in a broader 
interpretation, including not only medical certification standards, but also requirements for training 
and certification of flight surgeons and other medical support personnel, diagnostic protocols, 
countermeasures, treatment protocols, environmental standards, post flight rehabilitation, and 
radiation standards for the station. In the areas without common standards, however, the standards of 
each Partner have been recognized until common standards are developed.  
3.1.4 Ongoing Integrated Medical Support.  The MMPB worked to establish principles of 
medical support and medical responsibility in nominal ongoing operations, in a degraded support 
capability, and in medical contingency situations. In nominal operations, the ISS Mission Control 
Center - Houston (MCC-H) is the controlling center, with the Crew Surgeon responsible for the 
medical care of all individuals on the ISS in cooperation with the crew surgeons assigned to a given 
ISS Increment by Partners having crewmembers onboard.  When ISS control is passed to another 
mission control center, medical responsibility is also assumed by that center. For example, the 
Mission Control Center - Moscow (MCC-M) took control of ISS support during a 2005 closure of the 
MCC-H due to a tropical hurricane.  Non-emergent ISS contingencies of medical relevance, including 
illness or injury, are addressed by the Integrated Medical Group (IMG), an international medical 
group distributed among the active MCCs.  Operational medical management supervises and directs 
the IMG through Space Medicine Operations Team (SMOT), a weekly private medical forum by 
treleconference.  
In operational situations where the capability of one or more ISS health support systems is 
degraded, the combined resources of all Partners’ components are considered in determining the 
ability of the remaining ISS systems to support the health and safety of the ISS crew.  To facilitate 
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this process, a commitment has been made and followed to share all necessary information among 
Partners in a timely fashion.  Furthermore, consistent with the humanitarian principles of medical 
care, the ISS Program has expressed determination to make any on-orbit medical capability available 
to all crewmembers as appropriate, and to cooperate in the analysis of samples and data. Non-
emergent medical situations with potential major operational impacts, such as situations requiring 
medical evacuation, are to be reported to the highest-level medical authority (MMPB) for review.  
However, in the event of a medical or health-threatening emergency onboard the ISS, in which there 
is insufficient time for consultations, the Crew Surgeon at the controlling MCC has the authority to 
choose the medical response and directly communicate the appropriate recommendations to the ISS 
Increment Flight Director.  
3.1.5 Consensus and Issue Resolution.  The ISS medical policy requires every effort to 
achieve consensus in medical and health decisions to best support the health of the crew.  With the 
principle of consensus in foremost consideration, and in keeping with NASA’s responsibility for 
overall Space Station management and safety, a detailed process for dispute resolution was adopted, 
but has never been invoked to the present time.  Generally, all Partner medical organizations are 
determined to achieving final and satisfactory conflict resolution and avoiding referral of medical 
decisions to non-medical management authorities. 
 
4. ISS Medical Requirements and Standards 
 
The development and implementation of written medical requirements based on the ISS IGA 
and MOUs is a complex, multi-dimensional process. During this process consideration is given to 
space and terrestrial medical knowledge and evidence, medical risk estimates, accepted standards of 
care in the Partner countries, engineering and planning considerations, as well as crew expectations 
and concerns. In light of these complexities, there has been an ongoing dialog between the medical 
community and the Program management to define the medical requirements for long duration space 
flight as accurately and completely as possible.  The baseline version of ISS Medical Operations 
Requirements Document (“ISS MORD”) was developed during the pre-operational period of the ISS 
medical organization (1997-1998), and was approved by the MMOP and the ISS Program in 
September of 1998. The first updated revision (Rev. A) was approved by all Partners and published 
by the ISS Program soon after the beginning of piloted ISS flight (December 2000). Four interim 
updates were published to this version between July 2002 and May of 2003.  In August of 2006, a 
new revision of medical requirements was adopted by the ISS program for implementation. The ISS 
medical organization redefined the requirements in a most unambiguous language complete with a 
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rationale and definition of “consequences of non-implementation”. Sustained efforts are still 
necessary to continuously upgrade the ground and ISS infrastructure of medical support to a more 
robust and sufficiently redundant level, in order to support a crew of six individuals without 
reductions in the ISS medical risk mitigation capacity.  
Substantial discordances among all ISS Partners' approaches to a variety of health and medical 
issues, including medical selection standards and certification criteria, prevented rapid development 
of joint medical standards. Following negotiations, in June of 1998 the MMOP adopted the NASA 
Astronaut Medical Evaluation Requirements Document (classified as AMERD 2A) as a temporary 
common standard for all Partners; a respective official protocol was signed. Few exceptions were 
defined in agency-specific Matrices, most of which referred to additional requirements levied by each 
Partner on their crewmembers. Several evaluation selection tests and examination were substituted by 
alternative methods. This management decision was necessary to enable the multilateral medical 
certification process by the MSMB. However, it soon became apparent that an updated set of 
common standards and evaluation lists was necessary to take advantage of the entire space medicine 
experience and the advances in modern evidence-based medicine. Furthermore, the need arose to 
define specific criteria and requirements for the selection of Space Flight participants (tourists), as the 
Russian space agency began offering seats on Soyuz vehicles to individuals that were not professional 
cosmonauts or astronauts.  
The first document of the new series received MMOP approval in May of 2002, and was 
entitled “Medical Standards and Certification Procedures for Space Flight Participants”. These 
standards were designed for individuals transported to the ISS for commercial visitation or other 
short-term purposes (less than 30 days), generally fare-paying passengers without operational duties 
or assignments. The new multilateral version of the standards for long-duration ISS crewmembers 
was approved in 2005-2006 as “Medical Evaluation Document Vol. A and B”.  The document 
includes causes for rejection, health and anthropometric standards, as well as medical evaluation 
requirements for selection and all phases of ISS missions.  
Flight Rules comprise a part of the ISS requirements documentation. The Flight Rules outline 
decisions planned in advance to minimize the amount of real-time discussion. Their importance is 
especially evident in view of the multilateral nature of the ISS Program. The ISS Flight rules are 
thoroughly coordinated documents organized in four volumes:  Volume B (ISS Generic Operational 
Flight Rules), Volume C - Joint Shuttle-ISS Operational Flight Rules, and Volume D (Soyuz/Progess 
Joint ISS Flight Rules). The majority of medically relevant flight rules, grouped in the “Aeromedical” 
sections (B-13, C-13 and D-13), are related to foreseeable limit violations (such as oxygen 
concentration in the respirable air), constraints or anomalies, and to mitigation of related medical 
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risks. Some flight rules are concise and self-explanatory, while others may be divided into sections 
and may contain an elaborate rationale and a list of references. All rules are maintained in both 
English and Russian languages, to ensure their immediate availability for real-time operational use. 
 
5. The Multilateral Space Medicine Board (MSMB) and Crew Medical Certification 
MSMB is a medical group comprised of 5 primary members (one from each agency). Alternate 
members are also identified. The role of this board is primarily clinical, and includes medical 
certification of the ISS crew and visiting crewmembers for space flight to ISS.  MSMB is also 
responsible for qualifying ISS flight surgeons from all Partners.  
The MSMB determines the medical eligibility of ISS crewmember candidates for training 
(including hazardous training activities) and long-duration missions, in accordance with medical 
standards adopted in the MED Vol. A document.  The MSMB also medically certifies all persons 
visiting the ISS aboard the Soyuz and Shuttle missions for the duration of docked operations, 
including Space Flight Participants (individuals other than professional astronauts or cosmonauts, 
also referred to as “tourists”).  Each partner selects and certifies their crewmembers via their 
Agency’s Medical Board, and submits the individual medical data for approval by the MSMB. In its 
certification process, the MSMB follows the overarching principles of full disclosure of medical data, 
thorough clinical review with extensive use of available terrestrial and space medical evidence, and 
decision-making by consensus.  
Concerns that arise are resolved via clinical discussion (meetings, teleconferences, and 
electronic communications), inviting the assistance of clinical experts from various countries when 
necessary. In all such occasions, medical decisions are made within the medical groups. It is not 
uncommon for the MSMB to hear evidence review presentations in order to assess the probability of 
disease manifestations and the magnitude of medical and mission consequences in a given case, and 
to determine whether the combination of the risk and its available mitigation warrants justifiable 
clearance for the mission.  By May of 2007, the MSMB had held ??  meetings and teleconferences, to 
document ?? medical certification events (?? certification decisions for new candidates, ?? re-
certifications, and ?? temporary extensions of medical certification status), resulting in an average 
number of certification events of ?? per individual. 
 
6. The Multilateral Medical Operations Panel (MMOP) and ISS Medical Operations 
MMOP is the operationally oriented panel with one member from each agency. The MMOP is 
responsible for development of medical requirements, clinical standards, implementation plans, and 
operational procedures. The MMOP has dual reporting responsibilities: to the MMPB for issues 
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related to medical policy and to the ISS Program Office (Mission Integration and Operations Control 
Board, MIOCB) for operational issues.  The MMOP assembles monthly by a videoconference and 
operates on the principle of consensus. It is assisted by 11 multilateral Working Groups of special 
expertise (see Fig. 1: ISS multilateral medical authority structure.) Some of the important MMOP 
tasks are: control of the ISS Medical Operations Requirement Document (MORD), development of 
ISS medical standards, development of training requirements and guidelines for ISS crewmembers 
and flight surgeons, continuing evaluation of medical and environmental monitoring capability, and 
approval of mission medical readiness of Shuttle or Soyuz launches to the ISS.  The MMOP Working 
Groups include representation from all agencies with competence in the corresponding fields. The 
Working Groups perform a detailed analysis and discussion of issues and provide recommendations 
to the MMOP, thus playing a key role in introducing special partner approaches to the multilateral 
medical organization.   
 
6.1 The Approach to ISS Medical Status Review and Prognostic Evaluation 
The system of continuous mission status review and prognostic evaluation is an important 
feature of the ISS medical support.  The ISS Program’s medical organization has created an process 
of health-related information review that routinely combines recent data and anticipatory 
considerations on a daily, weekly, monthly, and per-increment basis (Fig. 3). The system maintains a 
firm grip on all the factors that allow timely identification and mitigation of medical and health risks.  
For every given moment, the medical status of the station and its crew has been previously addressed 
in a “forward-looking” fashion by the previous expedition readiness review, a previous monthly 
“look-ahead” review, the preceding week’s SMOT teleconference, and the daily interactions within 
the Integrated Medical Group (IMG). This continuous proactive process hinges on multilateral 
participation.  
 
6.1.1 Daily activities and status review (IMG) 
 
Depending on the mission schedule, various medical operations activities may be scheduled for 
a given day, such as medical and psychological conferences with the crew, medical testing, or IMedS 
data downloads and analysis. At the daily level, no formal multilateral events are conducted, and most 
activities involve only partners having a crewmember onboard.  The Crew Surgeon and Partner flight 
surgeons at the active MCCs are fully aware of all the activities and work as a virtual single group 
called the Integrated Medical Group (IMG). Environmental, radiation and similar data are shared as 
soon as they become available. Preparations are made for the events anticipated in the following days 
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or weeks, such as pre-EVA planning, exercise regimen adjustments, or sleep shifting coordination. 
The daily data are thoroughly documented and a daily status report is completed by the mission-
assigned biomedical engineers. The medical operations plans are coordinated with the ISS mission 
planning community and the engineering community if necessary. The Crew Surgeon or Deputy 
Crew Surgeon is available at all times for immediate communication with mission management, the 
crew, any mission support personnel, or the medical management of any Partner.  The ISS medical 
organization thus maintains, through the IMG, a current knowledge of the status of the crew health 
and activities, and is prepared for the activities of the following days. 
 
6.1.2 Weekly status review: Space Medicine Operations Team (SMOT) 
 
Since the beginning of piloted operations, Partners established a weekly operational medical 
forum by audio teleconference. Called SMOT, this forum is attended by the IMG flight surgeons and 
the operational medical management of all Partner agencies. Since the first event on November 08, 
2000, this forum has assembled weekly with no interruptions. With attendance limited to physicians 
and essential personnel, this is the only multilateral forum besides the MSMB certification events 
where medical issues are disclosed and openly addressed will representatives of all Partners.  
Each SMOT meeting follows a formal agenda that includes recurring Items (status reports), 
new items or concerns (issues submitted for discussion by any Partner), and announcements. Status 
reports from MCC-H are presented by the Crew Surgeon (or Deputy Crew surgeon), and the Partner 
flight surgeons. Standard report from MCC-M is provided by the Lead of the Group of Medical 
Support, and primarily focuses on the review of the Russian components of medical operations and 
data obtained through the Russian orbital segment. It is important to note that this report integrates 
information, positions, and concerns from all the medical organizations of the Russian partner, thus 
representing a unified Russian input.  
During the SMOT teleconferences that coincide with Soyuz or Shuttle flights to ISS, status 
reports are heard not from one, but two Crew Surgeons (arriving and departing crew), and surgeons 
assigned to the visiting crews or particular crewmembers. Such reports may be delivered from other 
locations, such as the NASA Kennedy Space Center or the Gagarin Cosmonaut Training Center in 
Russia. Such expansion of the SMOT is driven by the principle that during docked operations the ISS 
medical support system is primary, and the ISS Crew Surgeon is the lead of the IMG complement 
regardless of its current composition. 
At the end of each SMOT, the Partners cast a formal vote for approval of nominal ISS 
operations in the following week, based on medical considerations. While the complete SMOT 
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Protocol is documented and archived in a secure fashion, a “de-privatized” version, stripped of 
confidential data, is available to any working-level medical operations personnel to ensure the 
currency of their knowledge of the medically relevant circumstances of the mission. 
The SMOT, by the virtue of its unrestricted access to any and all information related to crew 
health on the one hand, and the authority of the medical managers present, on the other, is seen as the 
main pathway for short-term operational input into the ISS mission management through the ISS 
Mission Management Team. Such inputs can be made through a delegate to the MMT meeting, by 
special written communication on behalf of SMOT, or through the official SMOT protocol (with 
private data omitted), reflecting the concerns and recommendations. By May of 2006, SMOT had 
conducted over 330 weekly teleconferences. 
 
6.1.3 Monthly status review: Anticipatory (look-ahead) Medical Operations Status 
Reviews  
Beginning with ISS Expedition 9, the partners established a monthly anticipatory (look-
ahead) routine procedure to address operational situations and conditions for the near-term medical 
support of the ISS crew. These mandatory monthly reviews are scheduled in conjunction with the 
SMOT teleconferences. Any foreseeable factors that may disrupt the nominal progress of the mission 
from the medical perspective, or compromise the quality or adequacy of operational medical support,  
are brought up and discussed.  Generally, they follow an SMOT teleconference and consist of reports 
that identify special operational demands and circumstances of the following month, and estimate the 
degree of readiness of the IMedS and IMG to meet such demands. Examples have included 
predictions regarding exercise equipment life cycle limits, ambient noise concerns, or needs of 
pharmacy replenishment that would claim increased up-mass allocation. This activity has proven to 
be highly beneficial, as it mobilizes the medical operational personnel to be proactive and consider a 
longer-term outlook of all the circumstances surrounding the medical support of ISS mission. 
6.1.4 Integrated MMOP Review of Mission Medical Readiness  
After completion of agency-level readiness reviews, the MMOP Mission Readiness Review 
event is conducted (generally matched with the last monthly “look-ahead” review of the previous 
expedition, or an MMOP meeting).  Using a formal Launch Readiness Checklist, Partners develop a 
formal position of the medical organization regarding readiness for the next ISS increment (mission) 
in an integrated fashion. The resulting Launch Readiness Statement to the ISS Program addresses 
medical aspect of the upcoming mission, explicitly confirms availability of the required capabilities, 
and notes exemptions or exceptions. The Statement includes requests to the ISS Program regarding 
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high-priority aspects of the mission, or special concerns from the medical perspective (Table 1). The 
Launch Readiness Statement is a culmination of the multi-level continuous anticipatory reviews 
system. The MMOP generates readiness statements for non-crew exchange missions as well, if they 
have any medical implications such as visiting crew flight to ISS). 
 
6.2 The Integrated Medical System (IMedS) 
 
Although medical and countermeasures hardware and inflight medical operations plans are 
originally divided by origin (supplying agency), they are utilized and executed in an integrated 
fashion. The policy-level support of the medical system integration allowed the entire medical 
support infrastructure aboard the Station to be treated as the ISS Integrated Medical System (IMedS).  
The realization of the IMedS concept united the NASA Crew Health Ccare System (CHeCS) as 
overseen by the Johnson Space Center, the Russian medical hardware as overseen by the Russian 
Medical Support Group, and conceivably other Partners’ future medical equipment, under a single 
unified working concept.  When evaluating medical aspects of new mission plans (including mission 
readiness review), medical personnel presents the results to the ISS Program in an integrated fashion, 
meaning decisions have already been coordinated among all ISS medical counterparts.  Joint 
procedures are integrated into the common Station Operations Data File books, and ground 
documentation such as the ISS Medical Hardware Catalog, which consolidates all medical equipment 
descriptions into a single volume.  
In similarity with the medical support hardware, the ISS medical kits with medication, medical 
and dental tools and examination devices, dressings, splints, and other small portable medical items, 
are the responsibility of the agency of origin but united in the same concept of integrated medical 
assets.  The medical items of all origins are always considered when a medical capability for a given 
situation is assessed.  
The capabilities of the IMedS are remarkably robust when compared with any previous space 
program. Diagnostic equipment, besides electrophysiology and pulmonary function testing, includes a 
large number of blood and urine tests. For a medical contingency requiring imaging support, the 
IMedS can be augmented by a multipurpose ultrasound system available in the ISS Human Research 
Facility. For the first time in the history of human space flight, diagnostic imaging has become a 
required capability for medical risk mitigation [11,12]. 
 
6.3 Behavioral aspects of ISS missions 
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Any deterioration in behavioral health and performance, especially at critical operational points 
in the mission, may have direct impact on the mission’s safety and success [13,14]. Ineffective 
medical and behavioral support could increase the mission and medical risks due to fatigue, task 
overload, illness, low morale/motivation, or interpersonal frictions within the crew or between the 
crew and the ground personnel. Such deterioration may be insidious and may remain unnoticed for a 
long time, to present itself at a critical, unforgiving point when the demands for accuracy and 
efficiency are the highest.  
Successful behavioral health and performance monitoring and intervention require specialized 
expertise that is not always part of a physician’s training.  Therefore, the crew-assigned flight 
surgeons are assisted by behavioral health and performance specialists, who have been regularly 
involved with the crewmembers through all phases of the mission.  MMOP is supported by a 
Spaceflight Human Behavior and Performance Working Group (SHBPWG) since 1998, to coordinate 
Partner inputs regarding behavior, performance and psychological factors and requirements for long-
duration space flight, psychological characteristics and needs of multicultural crews, and crew 
psychological training and support. The vast experience and immediate operational involvement of its 
members in their home agencies allowed the group to not only respond to MMOP actions, but also to 
proactively generate recommendations to the MMOP in the area of behavioral support and crew 
protection.  
The psychological state of the crewmembers and their performance has long been known to 
depend, among other factors, on their work-rest schedule, and maintenance of a stable circadian 
rhythm.[17]  The ISS medical organization makes consistent efforts to set limits to daily working 
hours, and to protect the personal time of crewmembers. Crew work time demands tend to sharply 
increase during docked operations and the preceding several days, around the time of cargo spacecraft 
arrivals, in cases of off-nominal conditions and system failures, and EVA events. Same events usually 
require circadian shifting, further complicating the crewmembers’ ability to rest and recuperate from 
intense work activities.  Every such instance requires extensive coordination among the IMG 
personnel with subsequent integration of the medical decisions into the crew timeline.   
 
7. Conclusions 
The ISS assembly and operation in the piloted mode has been ongoing for over 6 years, partly 
delayed due to various setbacks.  Currently, Expedition 15 is working aboard the station. The duration 
of expedition crew stays on orbit has ranged from 129 to 196 days. Throughout all of the ISS 
expeditions, the medical requirements were essentially met and medical operations were performed in 
accordance with multilaterally adopted documents, particularly the ISS MORD. The structure 
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established to manage medical operations permitted adequate response to occurring problems, thereby 
assuring crew health and a level of performance required to perform mission tasks. No serious clinical 
problems among crewmembers were observed neither aboard the station, nor in broader terms of the 
mission medical outcomes.  ISS life support systems were sufficient and adequate, and intermittent 
temporary failures of individual equipment did not affect crewmember health.   
The environmental conditions on the ISS during all flights have, on the whole, remained 
satisfactory and in conformance with the regulatory requirements of the ISS MORD.  Some concern 
was elicited by noise levels in certain areas of the station and by the occasional need to suppress 
microbial and fungal contamination of surfaces. The methodology developed to monitor the station’s 
environment provided adequate objective information to ensure healthy living and working 
environment for the crew. At the same time, addition of new modules and arrival of multiple cargo 
and transport vehicles tends to increase the integral contamination of the station air.   
The vast majority of the scheduled medical operational activities were completed. Failures of 
medical hardware were encountered, however without substantial impact on health, safety, or 
performance of the crews. The U.S. and Russian contributions to the IMedS, and the real-time 
mission operations have been partly redundant and largely complementary, and have ensured 
uninterrupted provision of essential medical services to the ISS Program. Expedition 14 marked the 
beginning of transition from bilateral to multilateral contribution, as the European Partner provided a 
long-duration crewmember (T. Reiter), and added it mission control capability to the previously 
bilateral mission control infrastructure. The The ISS Program apprears to be ready for further 
expansion of the roles of all ISS Partners, the eventual crew increase to six individuals, and to the 
assembly-complete utilization of the ISS. 
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Appendix 
 
 
 
 
11.4 NASA, CSA and other Partners will establish a Multilateral Medical Policy Board (MMPB) to provide coordination 
and oversight of crew health issues.  NASA and CSA will each provide single point of contact for medical support who 
will have full responsibility to resolve issues related to the development of a common system for medical support.  
The MMPB will be supported by a Multilateral Space Medicine Board (MSMB) and by a Multilateral Medical Operations 
Panel (MMOP), established by NASA and CSA with the other Partners, which will be the primary working level groups 
for coordination of crew health matters including clinical care, medical standards, preventative medicine (including 
operational countermeasures) and environmental monitoring.  The MMOP and the MSMB will operate on the principle 
of consensus.  The MMOP will develop medical standards, certification criteria, pre-flight, in-flight, and post-flight 
medical care requirements, medical hardware responsibilities and operational procedures and recommend them to 
the MSMB for approval.  The MSMB will present its decisions and findings to the MMPB and MCOP, as appropriate, for 
review and concurrence.  NASA, CSA, and the other Partners will be responsible for medical certification of their 
respective crew member in accordance with agreed standards, and will present the appropriate documentation to the 
MSMB for approval.  The MSMB will have responsibility for final medical certification of crew and for oversight of the 
implementation of medical operations.   
 
Authors’ Note: Article 11.4 in all four ISS MOU’s are identical, with the exception of the Partner’s name. 
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Figure Captions 
 
Figure 1: ISS multilateral medical boards, panels, and working groups. MMIOCB - 
Multilateral Mission Integration and Operations Control Board; MCOP - Multilateral Crew 
Operations Panel. 
 
Figure 2: The ISS Multilateral medical certification flowchart. 
 
Figure 3: The four layers of the ISS medical status and readiness review process. 
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Table 1. Areas of emphasis in the MMOP mission readiness review process 
 
Aspect of Readiness Primary Considerations 
Crew Medical Certification MSMB status of medical certification for all crewmembers (new ISS crew and 
visiting short-duration crewmembers). Russian or NASA approval for special medical 
aspects of the visiting vehicle (Soyuz or Shuttle). 
Crew Training Completion of all required biomedical training tasks. 
Evaluation and Monitoring of 
Crew Health and Performance 
The availability of necessary capabilities and equipment to perform basic evaluation 
and monitoring of health and performance of the crew on the station. 
Diagnostic and Treatment 
Capabilities 
The availability of equipment and capabilities to adequately diagnose and treat routine 
medical and dental problems and to perform cardiopulmonary resuscitation (CPR) and 
basic life support (BLS) procedures. 
The ISS Environment Water and air quality for permanent human presence, existence of plans and 
equipment for long-duration monitoring of environmental parameters. 
Sustaining Human Health The availability of capabilities and equipment to implement and monitor operational 
in-flight measures to maintain the human health and to mitigate undesirable effects of 
space flight. Adequacy reserves of provisions to assure crew dietary needs. 
Specific Areas Needing 
Attention 
Requests to the ISS Program to recognize areas of concern or special importance as 
high-priority areas for the mission. Example: request for “continued attention of the 
ISS Program to maintaining the functionality of all exercise countermeasures devices 
(RED, TVIS, VB-3 with force loaders, CEVIS, BD-1), as to a high-priority Program 
goal for sustaining crew health and performance throughout the expedition.”  
Summary An MMOP declaration regarding the absence or presence of medical constraints for 
the mission, per the readiness criteria in the current version of the ISS MORD.  
Example: “At the time of this review, no medical constraints exist to ISS 11 
Expedition and the 10S mission, per the agreed upon readiness requirements of ISS 
MORD Rev B.  The MMOP finds that the crew is fully prepared for this flight and the 
ISS is safe and operationally ready to support the arrival of the crew and the 
performance of their mission.” 
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